Skip to Content

Rising Biosciences Inc RBII

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RBII is trading at a 169% premium.
Price
$0.00
Fair Value
$5.95
Uncertainty
Extreme
1-Star Price
$3.30
5-Star Price
$7.66
Economic Moat
Qjnmd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RBII is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.01 / $0.03
Market Cap
$668.73
Volume/Avg
40,508 / 268,532

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
Website

Valuation

Metric
RBII
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
RBII
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
RBII
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRHkvpnmqbDldgfj$78.2 Bil
ZTS
Zoetis Inc Class ASkptjmdhqJtmj$78.0 Bil
HLN
Haleon PLC ADRJwmqwhgrYtxs$38.4 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRPtrfxrclMjybr$19.1 Bil
VTRS
Viatris IncCkppfdgwXdy$12.5 Bil
RDY
Dr Reddy's Laboratories Ltd ADRDpnwfwzwdSll$11.8 Bil
CTLT
Catalent IncRxkpfqhDwgtclw$9.9 Bil
PRGO
Perrigo Co PLCQpjzynxsHtrd$3.8 Bil
CURLF
Curaleaf Holdings IncPbpjzknbVngqv$3.5 Bil
PBH
Prestige Consumer Healthcare IncMfpvwfbqQxrjsk$3.2 Bil

Sponsor Center